PDF file       product list       search       home page       email       legal notice    

ABX  advanced biochemical compounds   

Catalogue
Number 		Product Order number / Unit
9721 HYNIC-TOC trifluoroacetate 9720.0001: 1 mg per vial
9720.0010: 10 mg per vial
Please inquire for customized filling and bulk quantities.
 
Precursor for [99mTc]HYNIC-TOC
Molar Mass: 1170.40
C55H71N13O12S2
[257943-19-4] (net peptide)
Colourless to off-white freeze-dried solid packaged in dark glass screw cap vials.
Purity: ≥ 95 %
Certificates:
CoA; MS (identity) and HPLC (purity)
Chemical Name:
CA index name: L-Cysteinamide, N-[(6-hydrazinyl-3-pyridinyl)carbonyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl- N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
Synonymes:
L-Cysteinamide, N-[(6-hydrazino-3-pyridinyl)carbonyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; HYNIC-[Tyr3] Octreotide
Literature:
1. Decristoforo C. et al. 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med. 2000, 27, 1318-25.
2. Decristoforo C. et al. 99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide. J Nucl Med. 2000, 41,1114-9.
3. Czepczynski, R. et al. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma. Eur J. Nucl. Med. Mol. Imaging. 2007, 34, 1635-45.
date of product catalogue issue: 05 April 2012

 
 
 

  PDF file       product list       home page       search       email       legal notice    

 
 
 

ICP License: 沪ICP备05000469号-1